Synopsis
Synopsis
0
VMF
0
Europe
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 4h-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-
2. Dihydrate, Ondansetron Monohydrochloride
3. Gr 38032f
4. Gr-38032f
5. Gr38032f
6. Hydrochloride, Ondansetron
7. Monohydrochloride Dihydrate, Ondansetron
8. Monohydrochloride, Ondansetron
9. Odt, Zofran
10. Ondansetron
11. Ondansetron Monohydrochloride
12. Ondansetron Monohydrochloride Dihydrate
13. Ondansetron, (+,-)-isomer
14. Ondansetron, (r)-isomer
15. Ondansetron, (s)-isomer
16. Sn 307
17. Sn-307
18. Sn307
19. Zofran
20. Zofran Odt
1. Ondansetron Hcl
2. 99614-01-4
3. Zofran
4. Ondemet
5. Emeset
6. Ondansetron (hydrochloride)
7. Zofran Odt
8. Nsc 665799
9. Ondansetronhydrochloride
10. 2999f27mad
11. Nsc-665799
12. C18h20cln3o
13. 4h-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-, Monohydrochloride
14. Emetron
15. 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one Hydrochloride
16. 9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4h-carbazol-4-one Hydrochloride
17. 9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-2,3-dihydro-1h-carbazol-4(9h)-one Hydrochloride
18. Smr000469179
19. Gr 38032
20. Unii-2999f27mad
21. Sr-01000763250
22. Zofran Preservative Free
23. Zofran And Dextrose In Plastic Container
24. Cpd000469179
25. Ondansetron Hydrochloride Preservative Free
26. 9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one Monohydrochloride
27. Schembl41455
28. Mls001304076
29. Mls001401397
30. Mls002222312
31. Regid_for_cid_68647
32. Gr 38032 Hcl
33. Ondansetron Hydrochloride, 98%
34. Chembl1201111
35. Ondansetron Hydrochloride- Bio-x
36. Ondansetron Hydrochloride And Dextrose In Plastic Container
37. Dtxsid701027913
38. Hms1571c18
39. Ondansetron Hydrochloride (zofran)
40. Hy-b0002
41. Ondansetron Hydrochloride And Sodium Chloride In Plastic Container
42. Mfcd00764297
43. Nsc665799
44. S1390
45. Ondansetron Hydrochloride [mi]
46. Akos015889292
47. Ab07046
48. Ccg-100852
49. Ccg-221058
50. Cs-1715
51. Gs-3597
52. H39o049
53. Nc00102
54. Ac-12464
55. Bo164177
56. Ondansetron Hydrochloride [who-dd]
57. Ondansetron Hydrochloride Anhydrous
58. O0407
59. Sw100810-5
60. Vu0424014-2
61. C90628
62. (+/-)-ondansetron Hydrochloride Anhydrous
63. A800774
64. Ondansetron Hydrochloride Anhydrous, (+/-)-
65. Q-201515
66. Sr-01000763250-5
67. Q27254405
68. 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one;hydrochloride
69. 1,2,3,4-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-9h-carbazol-4-one Hydrochloride
70. 4h-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-, Hydrochloride (1:1)
71. 9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1h-carbazol-4-one Hydrochloride
Molecular Weight | 329.8 g/mol |
---|---|
Molecular Formula | C18H20ClN3O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 329.1294900 g/mol |
Monoisotopic Mass | 329.1294900 g/mol |
Topological Polar Surface Area | 39.8 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 440 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Ondansetron hydrochloride |
Drug Label | The active ingredient in ZOFRAN Tablets and ZOFRAN Oral Solution is ondansetron hydrochloride (HCl) as the dihydrate, the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT3 receptor type. Chemically it is (1, 2, 3, 9-te... |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Tablet; Injectable; Solution |
Route | oral; Injection; Oral |
Strength | eq 4mg base; eq 2mg base/ml; eq 4mg base/5ml; eq 16mg; eq 16mg base; 16mg; eq 24mg base; eq 8mg base |
Market Status | Tentative Approval; Prescription |
Company | Amneal Pharms; Wockhardt; Silarx; Bedford; Hospira; Gland Pharma; Sun Pharm Inds (in); Teva; Apotex; Hikma Farmaceutica; Aurobindo Pharma; Natco Pharma; Taro; Sandoz; Par Pharm; Roxane; Glenmark Generics; Emcure Pharms; Fresenius Kabi Usa; Ipca Labs; Hikm |
2 of 6 | |
---|---|
Drug Name | Ondansetron hydrochloride preservative free |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2mg base/ml |
Market Status | Prescription |
Company | Wockhardt; Hospira; Teva; Hikma Farmaceutica; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Hikma Maple; Claris Lifesciences; Taro Pharms Ireland; Luitpold; Bedford Labs; Agila Speclts; Bd Rx |
3 of 6 | |
---|---|
Drug Name | Zofran preservative free |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2mg base/ml |
Market Status | Prescription |
Company | Glaxosmithkline |
4 of 6 | |
---|---|
Drug Name | Ondansetron hydrochloride |
Drug Label | The active ingredient in ZOFRAN Tablets and ZOFRAN Oral Solution is ondansetron hydrochloride (HCl) as the dihydrate, the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT3 receptor type. Chemically it is (1, 2, 3, 9-te... |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Tablet; Injectable; Solution |
Route | oral; Injection; Oral |
Strength | eq 4mg base; eq 2mg base/ml; eq 4mg base/5ml; eq 16mg; eq 16mg base; 16mg; eq 24mg base; eq 8mg base |
Market Status | Tentative Approval; Prescription |
Company | Amneal Pharms; Wockhardt; Silarx; Bedford; Hospira; Gland Pharma; Sun Pharm Inds (in); Teva; Apotex; Hikma Farmaceutica; Aurobindo Pharma; Natco Pharma; Taro; Sandoz; Par Pharm; Roxane; Glenmark Generics; Emcure Pharms; Fresenius Kabi Usa; Ipca Labs; Hikm |
5 of 6 | |
---|---|
Drug Name | Ondansetron hydrochloride preservative free |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2mg base/ml |
Market Status | Prescription |
Company | Wockhardt; Hospira; Teva; Hikma Farmaceutica; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Hikma Maple; Claris Lifesciences; Taro Pharms Ireland; Luitpold; Bedford Labs; Agila Speclts; Bd Rx |
6 of 6 | |
---|---|
Drug Name | Zofran preservative free |
Active Ingredient | Ondansetron hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2mg base/ml |
Market Status | Prescription |
Company | Glaxosmithkline |
Treatment of alcohol use disorder
Serotonin 5-HT3 Receptor Antagonists
Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS. (See all compounds classified as Serotonin 5-HT3 Receptor Antagonists.)
Antipruritics
Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16317
Submission : 2002-12-13
Status : Active
Type : II
Certificate Number : R1-CEP 2005-056 - Rev 00
Issue Date : 2012-05-24
Type : Chemical
Substance Number : 2016
Status : Valid
NDC Package Code : 64567-0005
Start Marketing Date : 2009-08-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Registration Number : 221MF10130
Registrant's Address : 8-2-337, Road No. 3,Banjara Hills,Hyderabad 500 034,TELANGANA,INDIA
Initial Date of Registration : 2009-06-30
Latest Date of Registration : --
NDC Package Code : 55111-017
Start Marketing Date : 2010-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-09-23
Pay. Date : 2015-09-09
DMF Number : 15436
Submission : 2001-05-15
Status : Active
Type : II
Certificate Number : R1-CEP 2005-071 - Rev 06
Issue Date : 2023-05-23
Type : Chemical
Substance Number : 2016
Status : Valid
Registration Number : 302MF10019
Registrant's Address : 8-2-337, Road No. 3,Banjara Hills,Hyderabad 500 034,TELANGANA,INDIA
Initial Date of Registration : 2020-01-31
Latest Date of Registration : --
Date of Issue : 2022-06-08
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043Amended
Address of the Firm :
NDC Package Code : 55111-017
Start Marketing Date : 2010-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16976
Submission : 2003-11-25
Status : Active
Type : II
Certificate Number : R0-CEP 2009-191 - Rev 02
Issue Date : 2014-03-31
Type : Chemical
Substance Number : 2016
Status : Expired
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16786
Submission : 2003-09-04
Status : Active
Type : II
Certificate Number : R1-CEP 2004-209 - Rev 03
Issue Date : 2020-03-04
Type : Chemical
Substance Number : 2016
Status : Valid
Date of Issue : 2022-09-01
Valid Till : 2025-07-02
Written Confirmation Number : WC-0074
Address of the Firm :
NDC Package Code : 65691-0035
Start Marketing Date : 2003-09-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15783
Submission : 2001-12-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16317
Submission : 2002-12-13
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2015-09-23
Pay. Date : 2015-09-09
DMF Number : 15436
Submission : 2001-05-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16976
Submission : 2003-11-25
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16786
Submission : 2003-09-04
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-10-23
Pay. Date : 2018-09-13
DMF Number : 15752
Submission : 2001-12-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15783
Submission : 2001-12-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15724
Submission : 2001-11-15
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-08-17
Pay. Date : 2021-08-12
DMF Number : 16710
Submission : 2003-07-15
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-02-25
Pay. Date : 2020-02-20
DMF Number : 15990
Submission : 2002-05-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16562
Submission : 2003-04-23
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
RLD : No
TE Code :
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : SOLUTION;ORAL
Dosage Strength : EQ 4MG BASE/5ML
Approval Date : 2007-11-30
Application Number : 77009
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 4MG BASE
Approval Date : 2011-03-28
Application Number : 77729
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 8MG BASE
Approval Date : 2011-03-28
Application Number : 77729
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 24MG BASE
Approval Date : 2011-03-28
Application Number : 77729
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 2MG BASE/ML
Approval Date : 2008-03-21
Application Number : 78014
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 4MG BASE
Approval Date : 2007-06-25
Application Number : 77306
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : ONDANSETRON HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 8MG BASE
Approval Date : 2007-07-31
Application Number : 78539
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Brand Name : ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 2MG BASE/ML
Approval Date : 2006-12-26
Application Number : 76780
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.64MG BASE/ML
Approval Date : 2007-02-26
Application Number : 76978
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 2MG BASE/ML
Approval Date : 2006-11-22
Application Number : 76759
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?